ENDO INTERNATIONAL PLC

(ENDP)
  Report
Real-time Estimate Cboe BZX  -  10:38 2022-08-19 am EDT
0.5020 USD   +23.74%
08/17Health Care Down as Rebound Runs out of Steam - Health Care Roundup
DJ
08/17GLOBAL MARKETS LIVE : Lowe's, Target, Apple, Alphabet, Amazon...
MS
08/17Endo International Files for Chapter 11 Bankruptcy Protection
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Communiqués de presse de la société ENDO INTERNATIONAL PLC
08/17ENDO INTERNATIONAL : Enters Into Restructuring Support Agreement with Senior Secured Debth..
PU
08/17ENDO INTERNATIONAL PLC : Bankruptcy or Receivership, Change in Directors or Principal Offi..
AQ
08/16Endo Enters Into Restructuring Support Agreement with Senior Secured Debtholders to Str..
PR
08/10Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Ad..
AQ
08/09ENDO INTERNATIONAL : REPORTS SECOND-QUARTER 2022 FINANCIAL RESULTS - Form 8-K
PU
08/09ENDO : Q2 Earnings Snapshot
AQ
08/09ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and..
AQ
08/09Endo reports second-quarter 2022 financial results
PR
08/08Paladin Labs Announces Health Canada's Filing Acceptance of Cenobamate Tablets as an Ad..
AQ
07/28ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/15ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/15Quoin Pharmaceuticals and Endo Ventures Limited Enter Into Exclusive Distribution and S..
AQ
07/01ENDO INTERNATIONAL PLC : Notice of Delisting or Failure to Satisfy a Continued Listing Rul..
AQ
07/01Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor
PR
07/01Opana® ER Antitrust Trial Concludes With Jury Verdict in Endo's Favor
AQ
07/01Endo Provides Top-Line Results from Phase 2 Study of Collagenase Clostridium Histolytic..
AQ
06/30ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
06/13Endo Executes Agreement With TLC to Commercialize Phase 3 Orthopedic Product for the Tr..
PR
06/13TLC Announces TLC599 Agreement with Endo
AQ
06/09ENDO INTERNATIONAL PLC : Submission of Matters to a Vote of Security Holders, Financial St..
AQ
06/09National Survey of Over 1,500 Men Shows More Than Half Were Unsure of How to Improve Th..
PR
05/06ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and..
AQ
05/05ENDO : Q1 Earnings Snapshot
AQ
05/05Endo reports first-quarter 2022 financial results
PR
05/05Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histol..
PR
05/03Endo Ventures acquires six injectable product candidates from Nevakar Injectables
AQ
05/02ENDO INTERNATIONAL : Acquires Six Development-Stage, Ready-to-Use Injectable Product Candi..
PU
05/02ENDO INTERNATIONAL PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/02Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Ne..
PR
05/02Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Ne..
AQ
05/02Nevakar Injectables Sells Six Development-Stage, Ready-to-Use Injectable Product Candid..
AQ
04/29ENDO INTERNATIONAL : Results of Operations and Financial Condition - Form 8-K
PU
04/20Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judg..
AQ
04/12Endo to Announce First-Quarter 2022 Financial Results
PR
03/30West Virginia reaches $26M settlement with opioid maker Endo
AQ
03/28Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials
PR
03/03Endo Launches New Living Our Values Program to Recognize Outstanding Team Members
PR
03/02BUTT FIRST : Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostri..
PR
03/01ENDO : Q4 Earnings Snapshot
AQ
03/01ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and..
AQ
03/01ENDO INTERNATIONAL : Q4 2021 Endo International plc Earnings Conference Call
PU
02/28ENDO INTERNATIONAL : REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS - Form 8-..
PU
02/28Endo reports fourth-quarter and full-year 2021 financial results
PR
02/11Endo Comments on Default Judgment on Liability in Tennessee State Court
PR
02/07Endo Announces Launch of Ready-to-Use VASOSTRICT® (vasopressin injection, USP) in Pre-M..
PR
01/25Endo to Announce Fourth Quarter and Full-Year 2021 Financial Results
PR
01/18Endo Reaches Agreement Intended to Settle Florida Governmental Opioid Cases and Claims
PR
01/17Paladin Labs Announces the Launch of Xydalba® (dalbavancin for injection) in Canada
AQ
01/13Endo Announces Publication of New AVEED® (testosterone undecanoate) Data in Peer-Review..
PR
01/11Endo Launches New Dupuytren's Contracture Campaign Featuring Real Patients, Watching Ed..
AQ
01/11ENDO INTERNATIONAL : at J.P. Morgan Healthcare Conference
PU
01/11ENDO INTERNATIONAL PLC : Regulation FD Disclosure (form 8-K)
AQ
01/11Endo Appoints Dr. James P. Tursi as Executive Vice President, Global Research & Develop..
PR
01/10ENDO LAUNCHES NEW DUPUYTREN'S CONTRA : Watching Education Unfold
PR
01/05Endo Launches First Generic Version of CUVPOSA (glycopyrrolate) Oral Solution
AQ
01/04Endo Launches First Generic Version of CUVPOSA® (glycopyrrolate) Oral Solution
AQ
01/04Endo to Participate at J.P. Morgan 40th Annual Healthcare Conference
PR
2021Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPR..
AQ
2021Endo Reaches Agreement Intended to Settle Texas Governmental Opioid Cases and Claims
AQ
2021Endo Announces Agreement for Paladin Labs to Commercialize SK Biopharmaceuticals' XCOPR..
PR
2021Endo Announces Favorable Final Ruling in California State Court Opioid Trial
PR
2021ENDO INTERNATIONAL : Public Statement Against Use of Medicines for Capital Punishment
PU
2021Endo's Qwo® (collagenase clostridium histolyticum-aaes) Data Presented at the American ..
AQ
2021Endo Begins Shipment of Generic MIACALCIN® (calcitonin salmon) Injection
PR
2021Endo Announces Fill-Finish Manufacturing Agreement with U.S. Government to Support Prod..
AQ
2021Endo Announces Agreement with Premier to Supply VASOSTRICT (vasopressin injection, USP)..
AQ
2021Endo Announces Agreement with Premier to Supply VASOSTRICT® (vasopressin injection, USP..
PR
2021ENDO INTERNATIONAL PLC Management's Discussion and Analysis of Financial Condition and..
AQ
2021Q3 2021 Endo International plc Earnings Conference Call
PU
2021ENDO : Q3 Earnings Snapshot
AQ
2021ENDO REPORTS THIRD-QUARTER 2021 FINANCIAL RESULTS AND RAISES 2021 FINANCIAL GUIDANCE - ..
PU
2021ENDP Q3 2021 Slides
PU
2021ENDO INTERNATIONAL PLC : Results of Operations and Financial Condition (form 8-K)
AQ
2021Endo Reports Third-Quarter 2021 Financial Results And Raises 2021 Financial Guidance
PR
2021ENDO INTERNATIONAL PLC : Change in Directors or Principal Officers (form 8-K)
AQ
1  2  3Next
Upcoming event on ENDO INTERNATIONAL PLC